Update shared on20 Sep 2025
Fair value Decreased 7.94%The downward revision of JBT Marel's consensus analyst price target primarily reflects a decline in the anticipated future P/E ratio, with fair value lowered from $162.30 to $149.42.
What's in the News
- JBT Marel is showcasing several innovations at Pack Expo Las Vegas, including the launch of the CIPure Cleaning System, new juicing and pet food technologies, tray sealers, slicers, and a 3D model of a fresh salad line, alongside immersive VR experiences.
- The company re-established 2025 earnings guidance, projecting revenue between $3,675 million and $3,725 million, a loss from continuing operations margin of 2.7% to 1.7%, GAAP LPS of $1.90 to $1.20, and a $70 million to $85 million positive FX impact.
- JBT Marel was added to the Russell 2000 Dynamic Index.
Valuation Changes
Summary of Valuation Changes for JBT Marel
- The Consensus Analyst Price Target has fallen from $162.30 to $149.42.
- The Future P/E for JBT Marel has fallen from 22.13x to 20.42x.
- The Discount Rate for JBT Marel remained effectively unchanged, moving only marginally from 8.55% to 8.63%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.